Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis.

Wang, Jie; Chen, Hongyu; Tang, Zihuan; Zhang, Jinquan; Xu, Yuanwei; Wan, Ke; Hussain, Kifah; Gkoutos, Georgios V; Han, Yuchi; Chen, Yucheng

Wang, Jie; Chen, Hongyu; Tang, Zihuan; Zhang, Jinquan; Xu, Yuanwei; Wan, Ke; Hussain, Kifah; Gkoutos, Georgios V; Han, Yuchi; Chen, Yucheng.

Afiliação

Wang J; Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chen H; College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Tang Z; West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
Zhang J; West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
Xu Y; Division of Informatics, Imaging, and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Wan K; Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Hussain K; Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Gkoutos GV; Department of Cardiology, NorthShore University Health Systems, Evanston, Illinois, USA.
Han Y; College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Chen Y; Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

EClinicalMedicine ; 63: 102172, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37662524

Palavras-chave

ATTR; Prognosis; Tafamidis; Transthyretin amyloid cardiomyopathy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google